ALLG will take part in Australia’s first Blood Cancer Taskforce, announced yesterday by Minister Greg Hunt and established in collaboration with the Leukaemia Foundation of Australia, which [...]
This week, ALLG’s National Blood Cancer Registry (NBCR) contributed to a new study on acute myeloid leukaemia (AML) published in the Journal of Clinical Oncology.
Cara Markovic joins the ALLG with over 15 years of experience in the medical device industry. A PhD qualified physiologist by training, she has held various scientific and marketing roles in [...]
As part of the EHA conference, Prof Harry Iland launched the APML5 interim clinical trial results, a comparative bioavailability study of oral sodium hydrogen diarsenic tetroxide and intravenous [...]